MiR-125b targets ARID3B in breast cancer cells

Cell Structure and Function

Volumn 37, Issue 1, 2012, Pages 27-38

  Akhavantabasi, Shiva ^a   Sapmaz, Aysegul ^a   Tuna, Serkan ^a   Erson Bensan, Ayse Elif ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

Author keywords

MiR 125b ARID3B ERBB2

Indexed keywords

AT RICH INTERACTIVE DOMAIN 3B PROTEIN; BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; MICRORNA 125B; UNCLASSIFIED DRUG; ARID3B PROTEIN, HUMAN; DNA BINDING PROTEIN; ERBB2 PROTEIN, HUMAN; MICRORNA; MIRN125 MICRORNA, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; PHALLOIDIN; RENILLA LUCIFERIN 2 MONOOXYGENASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL MIGRATION; CELL MOTION; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; 3' UNTRANSLATED REGION; BIOSYNTHESIS; BREAST TUMOR; CELL SHAPE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; RNA INTERFERENCE; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SHAPE; DNA-BINDING PROTEINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES, RENILLA; MICRORNAS; PHALLOIDINE; PHOSPHORYLATION; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-2; RNA INTERFERENCE;

EID: 84861303000     PISSN: 03867196     EISSN: 13473700     Source Type: Journal    
DOI: 10.1247/csf.11025     Document Type: Article

References (41)

1. Akhavantabasi, S., Akman, H.B., Sapmaz, A., Keller, J., Petty, E.M., and Erson, A.E. 2010. USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers. Mamm. Genome, 21: 388-397.
2. Bartel, D. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116: 281-297.
3. Betel, D., Wilson, M., Gabow, A., Marks, D.S., and Sander, C. 2008. The microRNA.org resource: targets and expression. Nucleic Acids Res., 36: D149-153.
4. Bloomston, M., Frankel, W., Petrocca, F., Volinia, S., Alder, H., Hagan, J., Liu, C., Bhatt, D., Taccioli, C., and Croce, C. 2007. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA, 297: 1901-1908.
5. Bousquet, M., Quelen, C., Rosati, R., Mansat-De Mas, V., La Starza, R., Bastard, C., Lippert, E., Talmant, P., Lafage-Pochitaloff, M., Leroux, D., Gervais, C., Viguié, F., Lai, J., Terre, C., Beverlo, B., Sambani, C., Hagemeijer, A., Marynen, P., Delsol, G., Dastugue, N., Mecucci, C., and Brousset, P. 2008. Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J. Exp. Med., 205: 2499-2506.
6. Calin, G. and Croce, C. 2006. MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6: 857-866.
7. Casanova, J.C., Uribe, V., Badia-Careaga, C., Giovinazzo, G., Torres, M., and Sanz-Ezquerro, J.J. 2011. Apical ectodermal ridge morphogenesis in limb development is controlled by Arid3b-mediated regulation of cell movements. Development, 138: 1195-1205.
8. Cimen, I., Tunçay, S., and Banerjee, S. 2009. 15-Lipoxygenase-1 expression suppresses the invasive properties of colorectal carcinoma cell lines HCT-116 and HT-29. Cancer Sci., 100: 2283-2291.
9. Cowden Dahl, K.D., Dahl, R., Kruichak, J.N., and Hudson, L.G. 2009. The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. Neoplasia, 11: 1208- 1215.
10. Erson, A., Niell, B., DeMers, S., Rouillard, J., Hanash, S., and Petty, E. 2001. Overexpressed genes/ESTs and characterization of distinct ampli-cons on 17q23 in breast cancer cells. Neoplasia, 3: 521-526.
11. Erson, A. and Petty, E. 2008. MicroRNAs in development and disease. Clin. Genet., 74: 296-306.
12. Erson, A. and Petty, E. 2009. miRNAs and cancer: New research developments and potential clinical applications. Cancer Biol. Ther., 8: 2317-2322.
13. Fisher, C.L. and Pei, G.K. 1997. Modification of a PCR-based site-directed mutagenesis method. Biotechniques, 23: 570-571, 574.
14. Friedman, R.C., Farh, K.K., Burge, C.B., and Bartel, D.P. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 19: 92-105.
15. Griffiths-Jones, S., Saini, H.K., van Dongen, S., and Enright, A.J. 2008. miRBase: tools for microRNA genomics. Nucleic Acids Res., 36: D154-158.
16. Guan, Y., Yao, H., Zheng, Z., Qiu, G., and Sun, K. 2011. MiR-125b targets BCL3 and suppresses ovarian cancer proliferation. Int. J. Cancer, 128: 2274-2283.
17. Hofmann, M., Heinrich, J., Radziwil, G., and Moelling, K. 2009. A short hairpin DNA analogous to miR-125b inhibits C-Raf expression, proliferation, and survival of breast cancer cells. Mol. Cancer Res., 7: 1635-1644.
18. Huang, L., Luo, J., Cai, Q., Pan, Q., Zeng, H., Guo, Z., Dong, W., Huang, J., and Lin, T. 2011. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int. J. Cancer, 128: 1758-1769.
19. Iorio, M., Ferracin, M., Liu, C., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., Ménard, S., Palazzo, J., Rosenberg, A., Musiani, P., Volinia, S., Nenci, I., Calin, G., Querzoli, P., Negrini, M., and Croce, C. 2005. MicroRNA gene expression deregulation in human breast cancer. Cancer Res., 65: 7065-7070.
20. Iorio, M., Visone, R., Di Leva, G., Donati, V., Petrocca, F., Casalini, P., Taccioli, C., Volinia, S., Liu, C., Alder, H., Calin, G., Ménard, S., and Croce, C. 2007. MicroRNA signatures in human ovarian cancer. Cancer Res., 67: 8699-8707.
21. Kertesz, M., Iovino, N., Unnerstall, U., Gaul, U., and Segal, E. 2007. The role of site accessibility in microRNA target recognition. Nat. Genet., 39: 1278-1284.
22. Kobayashi, K., Era, T., Takebe, A., Jakt, L.M., and Nishikawa, S. 2006. ARID3B induces malignant transformation of mouse embryonic fibro-blasts and is strongly associated with malignant neuroblastoma. Cancer Res., 66: 8331-8336.
23. Krek, A., Grun, D., Poy, M.N., Wolf, R., Rosenberg, L., Epstein, E.J., MacMenamin, P., da Piedade, I., Gunsalus, K.C., Stoffel, M., and Rajewsky, N. 2005. Combinatorial microRNA target predictions. Nat. Genet., 37: 495-500.
24. Livak, K.J. and Schmittgen, T.D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25: 402-408.
25. Lu, J., Getz, G., Miska, E., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B., Mak, R., Ferrando, A., Downing, J., Jacks, T., Horvitz, H., and Golub, T. 2005. MicroRNA expression profiles classify human cancers. Nature, 435: 834-838.
26. Mattie, M., Benz, C., Bowers, J., Sensinger, K., Wong, L., Scott, G., Fedele, V., Ginzinger, D., Getts, R., and Haqq, C. 2006. Optimized high-throughput microRNA expression profiling provides novel bio-marker assessment of clinical prostate and breast cancer biopsies. Mol. Cancer, 5: 24.
27. Numata, S., Claudio, P.P., Dean, C., Giordano, A., and Croce, C.M. 1999. Bdp, a new member of a family of DNA-binding proteins, associates with the retinoblastoma gene product. Cancer Res., 59: 3741-3747.
28. Orom, U.A., Nielsen, F.C., and Lund, A.H. 2008. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell, 30: 460-471.
29. Ozek, N.S., Tuna, S., Erson-Bensan, A.E., and Severcan, F. 2010. Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy. Analyst, 135: 3094-3102.
30. Park, N.J., Zhou, H., Elashoff, D., Henson, B.S., Kastratovic, D.A., Abemayor, E., and Wong, D.T. 2009. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin. Cancer Res., 15: 5473-5477.
31. Rajabi, H., Jin, C., Ahmad, R., McClary, C., Joshi, M.D., and Kufe, D. 2010. MUCIN 1 Oncoprotein Expression is Suppressed by the Mir-125b Oncomir. Genes Cancer, 1: 62-68.
32. Sade, A., Tuncay, S., Cimen, I., Severcan, F., and Banerjee, S. 2011. Cele-coxib reduces fluidity and decreases metastatic potential of colon cancer cell lines irrespective of COX-2 expression. Biosci. Rep., 32: 35-44.
33. Scott, G., Goga, A., Bhaumik, D., Berger, C., Sullivan, C., and Benz, C. 2007. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J. Biol. Chem., 282: 1479-1486.
34. Selcuklu, S.D., Yakicier, M.C., and Erson, A.E. 2009. An investigation of microRNAs mapping to breast cancer related genomic gain and loss regions. Cancer Genet. Cytogenet., 189: 15-23.
35. Spector, A.A. and Yorek, M.A. 1985. Membrane lipid composition and cellular function. J. Lipid Res., 26: 1015-1035.
36. Spencer, K.S., Graus-Porta, D., Leng, J., Hynes, N.E., and Klemke, R.L. 2000. ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases. J. Cell Biol., 148: 385-397.
37. Tsai, C.M., Levitzki, A., Wu, L.H., Chang, K.T., Cheng, C.C., Gazit, A. and Perng, R.P. 1996. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells. Cancer Res., 56: 1068-1074.
38. Vasudevan, S., Tong, Y., and Steitz, J. 2007. Switching from repression to activation: microRNAs can up-regulate translation. Science, 318: 1931-1934.
39. Wilsker, D., Patsialou, A., Dallas, P.B., and Moran, E. 2002. ARID proteins: a diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development. Cell Growth Differ., 13: 95-106.
40. Wong, T., Liu, X., Wong, B., Ng, R., Yuen, A., and Wei, W. 2008. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin. Cancer Res., 14: 2588-2592.
41. Zhang, Y., Yan, L.X., Wu, Q.N., Du, Z.M., Chen, J., Liao, D.Z., Huang, M.Y., Hou, J.H., Wu, Q.L., Zeng, M.S., Huang, W.L., Zeng, Y.X., and Shao, J.Y. 2011. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res., 71: 3552-3562.